| Literature DB >> 20382989 |
Thomas Alcorn1, Douglas H Juers.
Abstract
Cryogenic cooling of macromolecular crystals is commonly used for X-ray data collection both to reduce crystal damage from radiation and to gather functional information by cryogenically trapping intermediates. However, the cooling process can damage the crystals. Limiting cooling-induced crystal damage often requires cryoprotection strategies, which can involve substantial screening of solution conditions and cooling protocols. Here, recent developments directed towards rational methods for cryoprotection are described. Crystal damage is described in the context of the temperature response of the crystal as a thermodynamic system. As such, the internal and external parts of the crystal typically have different cryoprotection requirements. A key physical parameter, the thermal contraction, of 26 different cryoprotective solutions was measured between 294 and 72 K. The range of contractions was 2-13%, with the more polar cryosolutions contracting less. The potential uses of these results in the development of cryocooling conditions, as well as recent developments in determining minimum cryosolution soaking times, are discussed.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20382989 PMCID: PMC2852300 DOI: 10.1107/S090744490903995X
Source DB: PubMed Journal: Acta Crystallogr D Biol Crystallogr ISSN: 0907-4449
Figure 1Model for cooling-induced crystal damage. Cooling triggers contraction of the protein, lattice repacking and the consequent contraction and reshaping of the solvent channel (black outline; Juers & Matthews, 2001 ▶). If the internal liquid (light gray) does not contract enough to compensate, the unit cell bursts, much as a copper pipe carrying water can burst if it is cooled below the freezing point of water. Curved black arrows show a hypothetical flow of the liquid. In this example, an idealized perfect crystal is broken into three smaller domains.
Thermal contraction characteristics of cryosolutions in order of increasing contraction
| Cryoprotective agent | Concentration | ρRT ( | ρLT ( | ρliq | MW (g mol−1) | Specific volume change (σ) |
|---|---|---|---|---|---|---|
| Lithium acetate | 30 | 1.123 (3) | 1.148 (3) | N/A | 66.0 | −0.022 (3) |
| Glucose | 50 | 1.223 (3) | 1.257 (7) | N/A | 180.2 | −0.027 (6) |
| Xylose | 50 | 1.218 (4) | 1.256 (3) | N/A | 150.1 | −0.030 (4) |
| Sorbitol | 50 | 1.195 (3) | 1.233 (2) | N/A | 182.2 | −0.030 (3) |
| Magnesium acetate | 33 | 1.186 (3) | 1.231 (3) | N/A | 142.5 | −0.037 (3) |
| Xylitol | 50 | 1.186 (4) | 1.232 (2) | N/A | 152.2 | −0.038 (3) |
| Glycerol | 50 | 1.130 (3) | 1.181 (2) | 1.257 | 92.1 | −0.044 (3) |
| Sodium formate | 45 | 1.320 (3) | 1.393 (2) | N/A | 68.0 | −0.052 (2) |
| Sodium malonate | 45 | 1.356 (3) | 1.432 (4) | N/A | 148.1 | −0.053 (3) |
| Lithium chloride | 40 | 1.266 (3) | 1.340 (4) | N/A | 42.4 | −0.056 (4) |
| 1,6-Hexanediol | 50 | 0.999 (2) | 1.066 (1) | N/A | 118.2 | −0.063 (2) |
| Ethylene glycol | 50 | 1.064 (3) | 1.139 (2) | 1.110 | 62.1 | −0.066 (3) |
| PEG 200 | 50 | 1.083 (2) | 1.166 (2) | 1.124 | 200.0 | −0.071 (2) |
| PEG 400 | 50 | 1.085 (3) | 1.170 (2) | 1.125 | 400.0 | −0.072 (3) |
| PEP 426 | 50 | 1.055 (2) | 1.138 (3) | 1.050 | 426.0 | −0.073 (3) |
| 2,3-Butanediol | 50 | 1.027 (2) | 1.108 (2) | 0.994 | 90.1 | −0.073 (2) |
| PEG 600 | 50 | 1.085 (3) | 1.170 (3) | 1.120 | 600.0 | −0.073 (3) |
| Propylene glycol | 50 | 1.041 (2) | 1.126 (2) | 1.033 | 76.1 | −0.076 (3) |
| PEG 4000 | 50 | 1.083 (3) | 1.176 (4) | N/A | 4000.0 | −0.079 (4) |
| DMSO | 50 | 1.080 (2) | 1.176 (3) | 1.095 | 78.1 | −0.082 (3) |
| DP6 | 100 | 1.072 (1) | 1.169 (4) | N/A | N/A | −0.083 (3) |
| MPD | 50 | 0.986 (2) | 1.078 (2) | 0.918 | 118.2 | −0.085 (3) |
| DMF | 50 | 1.002 (2) | 1.120 (3) | 0.945 | 73.1 | −0.105 (3) |
| 2-Propanol | 50 | 0.909 (3) | 1.041 (2) | 0.783 | 60.1 | −0.126 (3) |
| Methanol | 50 | 0.907 (2) | 1.041 (2) | 0.787 | 32.0 | −0.129 (3) |
| Ethanol | 50 | 0.913 (2) | 1.052 (2) | 0.787 | 46.1 | −0.132 (3) |
Abbreviations: PEG, polyethylene glycol; PEP, pentaerythritol propoxylate; DMSO, dimethyl sulfoxide; MPD, 2-methyl-2,4-pentanediol; DMF, N,N-dimethylformamide.
All solutions were created to be 50%(w/w) at RT or, if this was not possible, at the maximum solubility. These concentrations can be converted to other measures as follows: %(w/v) = %(w/w) × ρRT and %(v/v) = %(w/w) × (ρRT/ρliq).
RT, room temperature (294 K); LT, low temperature (liquid nitrogen at ∼72 K); 3–19 measurements were made at each temperature and σ represents the statistical variation in the measurements.
Density of pure liquid at ∼298 K from the literature (Yaws, 1999 ▶) or from the manufacturer.
The fractional change in the specific volume with cooling, (Δν/νRT) = (−Δρ/ρLT); σ is the propagated uncertainty.
DP6 is a commonly used solution for cryogenic cooling of tissues (Rabin et al., 1998 ▶) and is composed of about 23%(w/v) each of DMSO and propylene glycol and 3%(w/v) glucose in a HEPES/phosphate/carbonate/KCl buffer.
Correlation matrix for various physical characteristics of cryoprotective agents and solutions (Yaws, 1999 ▶; Lide, 2004 ▶)
The lower matrix shows the correlation coefficient, with values higher than 0.95 in bold. The diagonal shows the number of data points for each characteristic. Not all parameters are defined or could be found for all materials. The upper matrix shows the number of data points used to calculated the coefficient. PA, polar surface area. BP, boiling point. ρliq, density at 298 K. ρRT, density at 294 K. B liq, thermal expansion coefficient at 298 K. P, vapour pressure at 298 K. MP, melting point. σ, surface tension at 298 K. MW, molecular weight. ρLT, density at 72 K. K OW, octanol/water partition coefficient. η, viscosity at 298 K. k liq, thermal conductivity at 298 K. Rnd, random number.
| Δν/νRT | PA | BP | ρliq | ρRT | log | MP | σ | MW | ρLT | PA | Log | η | MW | Rnd | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Δν/νRT | 20 | 19 | 12 | 10 | 20 | 10 | 11 | 13 | 9 | 14 | 20 | 19 | 14 | 10 | 11 | 20 | 20 |
| PA | 19 | 12 | 10 | 19 | 10 | 11 | 13 | 9 | 14 | 19 | 19 | 14 | 10 | 11 | 19 | 19 | |
| BP | 0.90 | 12 | 10 | 12 | 10 | 11 | 12 | 9 | 12 | 12 | 12 | 12 | 10 | 11 | 12 | 12 | |
| ρliq | 0.95 | 0.94 | 10 | 10 | 10 | 10 | 10 | 9 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | |
| ρRT | 0.94 | 0.91 | 20 | 10 | 11 | 13 | 9 | 14 | 20 | 19 | 14 | 10 | 11 | 20 | 20 | ||
| −0.93 | −0.94 | −0.93 | −0.92 | 10 | 10 | 10 | 9 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | ||
| log | −0.94 | −0.91 | −0.86 | −0.80 | 0.93 | 11 | 11 | 9 | 11 | 11 | 11 | 11 | 10 | 11 | 11 | 11 | |
| MP | 0.92 | 0.90 | 0.84 | 0.85 | 0.90 | −0.68 | −0.82 | 13 | 9 | 13 | 13 | 13 | 13 | 10 | 11 | 13 | 13 |
| σ | 0.91 | 0.91 | 0.94 | 0.93 | −0.94 | −0.94 | 0.77 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | |
| MW | 0.87 | 0.89 | 0.77 | 0.77 | 0.87 | −0.61 | −0.80 | 0.91 | 0.66 | 14 | 14 | 14 | 14 | 10 | 11 | 14 | 14 |
| ρLT | 0.86 | 0.89 | 0.83 | −0.87 | −0.60 | 0.85 | 0.90 | 0.83 | 20 | 19 | 14 | 10 | 11 | 20 | 20 | ||
| PA | 0.71 | 0.81 | 0.71 | 0.66 | 0.66 | −0.80 | −0.56 | 0.74 | 0.71 | 0.76 | 0.58 | 19 | 14 | 10 | 11 | 19 | 19 |
| Log | −0.69 | −0.79 | −0.56 | −0.85 | −0.85 | 0.87 | 0.25 | −0.57 | −0.88 | −0.66 | −0.90 | −0.78 | 14 | 10 | 11 | 14 | 14 |
| η | 0.61 | 0.68 | 0.71 | 0.65 | 0.59 | −0.64 | −0.71 | 0.46 | 0.75 | 0.52 | 0.52 | 0.69 | −0.55 | 10 | 10 | 10 | 10 |
| 0.58 | 0.65 | 0.61 | 0.69 | 0.60 | −0.84 | −0.60 | 0.29 | 0.80 | 0.19 | 0.55 | 0.82 | −0.68 | 0.72 | 11 | 11 | 11 | |
| MW | 0.00 | −0.02 | 0.77 | 0.77 | 0.09 | −0.61 | −0.80 | 0.91 | 0.66 | 1.00 | 0.14 | −0.37 | −0.66 | 0.52 | 0.19 | 20 | 20 |
| Rnd | −0.02 | 0.28 | −0.07 | −0.31 | −0.11 | 0.46 | −0.83 | 0.03 | −0.63 | 0.18 | −0.22 | 0.05 | 0.03 | −0.44 | −0.33 | 0.42 | 20 |
Physical characteristic of the 50%(w/w) cryosolution. Otherwise, the physical characteristics of the pure cryoprotective agents were used.
Excluding PEG.
Figure 2Plot of the measured thermal contraction (Δν/νRT) versus the calculated polar surface area of the cryosolution. Data are shown for the solutions from Table 1 ▶ at 50%(w/w) cryoprotective agent/water.
Figure 3Often the crystal-growth buffer (dots) needs to be exchanged for a different solution for successful cooling. The required internal cryoprotective solution (light gray) may be different from the external cryoprotective solution (dark gray).
Calculated equilibration times (t 0.5, t 0.9) for the diffusion of two different cryoprotective agents through the solvent channels of thermolysin crystals (about 50% solvent with 20 Å diameter channels)
t 0.5 and t 0.9 are the times required during a diffusion-based equilibration starting with no cryoprotective agent in the crystal for the concentration to become 50% or 90% of its final value, respectively. Methanol is the smallest cryoprotective agent studied, while sucrose is one of the largest.
| Approximate equilibration times ( | ||
|---|---|---|
| Crystal size | Methanol | Sucrose |
| Small (200 × 50 × 50 µm) | 3 s, 9 s | 9 s, 30 s |
| Large (500 × 200 × 200 µm) | 40 s, 2 min | 2 min, 7 min |